| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $256.1M | — | +4.7% |
| Cost of Revenue | $223.8M | — | +3.6% |
| Gross Profit | $32.3M | — | +13.1% |
| R&D Expense | $5.5M | — | -5.9% |
| SG&A Expense | $22.6M | — | +3.8% |
| Operating Income | $2.1M | — | +277.9% |
| Pre-tax Income | $84K | — | +102.9% |
| Income Tax | $2.6M | — | +53.8% |
| Net Income | -$2.5M | — | +45.8% |
| EPS (Basic) | -$0.07 | — | +46.2% |
| EPS (Diluted) | -$0.07 | — | +46.2% |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $89.1M | -9.4% | -18.5% |
| Accounts Receivable | $93.1M | +32.0% | +16.5% |
| Inventory | $252.3M | +8.8% | -4.2% |
| Current Assets | $442.1M | +7.8% | -3.9% |
| Total Assets | $972.5M | +3.1% | -3.4% |
| Current Liabilities | $156.7M | +20.9% |
| Line Item | 2026-03-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.9M | — | -115.4% |
| Capital Expenditures | $7.1M | — | -61.8% |
| Investing Cash Flow | -$7.1M | — | +61.8% |
| Financing Cash Flow | $781K | — | +573.3% |
| Free Cash Flow | -$10.0M | — | -2112.5% |
| +5.2% |
| Long-term Debt | $122.0M | -1.2% | -3.7% |
| Total Liabilities | $304.5M | +9.1% | -0.6% |
| Stockholders' Equity | $668.0M | +0.6% | -4.6% |